A professional multi-disciplinary team with extensive experience in the medical aesthetic industry.
Rami joined EndyMed in July 2018 as CFO, bringing with him extensive experience in finance in multi-cultural and global environments.
Rami joins ENDYMED from Syneron Medical, and brings 12 years’ experience in global high-tech and medical aesthetic industries.
In addition to his extensive experience in the field of finance, financial strategy, strategic international planning and regulation, Rami holds a B.Sc in Computer Sciences and Economics and an MA in Economics from the University of Haifa, and is a lecturer in Micro Economics for B.Sc students at the University of Haifa.
Sima joined ENDYMED in November 2018 as VP R&D, bringing with her extensive experience in the field of energy-based aesthetic technology. Sima holds a Ph.D. in Biomedical Engineering from the University of Tel Aviv.
Sima joins ENDYMED from Syneron-Candela, where she was Project Manager for product prototypes, first series and technical files, with experience in regulatory body submissions. Sima also held the position of Global Technology Director Body. Prior to Syneron-Candela, Sima was the Acoustic Team Manager at UltraShape Ltd.
Paul Iannelli joined ENDYMED Medical Inc., the US office, in 2013 in the position of National Sales Director, and was promoted to Vice President of Sales US in 2015. In 2018 Paul has taken on the role of General Manager of ENDYMED Inc. Paul brings many years experience in the field of medical aesthetics, having held positions at Eclipse Aesthetics and Alma Lasers prior to joining ENDYMED.
Dr. Itzchak Angel joins ENDYMED as Pharmaceutical and Regulatory Advisor. Dr. Angel is an accomplished executive in the Pharmaceutical Industry, with over 35 years’ experience in guiding strategic drug and business development in both large and emerging companies, as well as interfacing with high profile regulatory, government and industry leaders. Dr. Angel’s areas of expertise include ethical drug development; discovery, research and development; international regulatory affairs; and biologics, small molecules, stem cells, drug delivery and medical devices. Dr. Angel’s many professional accomplishments include 80 scientific publications and 9 patents.